Artivion Inc. (AORT), a cardiac and vascular surgery company specializing in aortic disease, is experiencing a banner year, with shares surging nearly 64% year-to-date to trade around $25.
The company manufactures, processes, and distributes medical devices and implantable human tissues that are used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and related surgical products, and implantable cardiac and vascular human tissues.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.